Skip to main content
VCbacked
Log inGet Started
IN

Intrommune Therapeutics

New York, United States
Last funding
Undisclosed
Series BFeb 2022

Intrommune Therapeutics is a New York-based biotechnology company.

BiotechnologyHealth CareTherapeutics
Backed byChemical Angel NetworkRobin Hood VenturesRed Bear AngelsTimberline Investments

About Intrommune Therapeutics

Who are Intrommune Therapeutics's investors?

Intrommune Therapeutics's investors include Chemical Angel Network, Robin Hood Ventures, Red Bear Angels, Timberline Investments.

Where is Intrommune Therapeutics headquartered?

Intrommune Therapeutics is headquartered in New York, United States.

What does Intrommune Therapeutics do?

Intrommune Therapeutics is a New York-based biotechnology company.

What stage is Intrommune Therapeutics at?

Intrommune Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Intrommune Therapeutics — Funding & Investors." VCBacked, February 8, 2022, https://www.vcbacked.co/company/intrommune-therapeutics. Accessed October 1, 2026.
APA
VCBacked. (2022). Intrommune Therapeutics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/intrommune-therapeutics
Wikipedia (cite web)
{{cite web |title=Intrommune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intrommune-therapeutics |website=VCBacked |access-date=October 1, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Founder contacts
m***@intrommune.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →
Similar in BiotechnologyView all
General CyberneticsBoston$15.3MTectora TherapeuticsNew York$55.0MSolstice OncologyBoston$225.0MN&E InnovationsSingapore$1.7MPartillion BioscienceLos Angeles$2.1MRidge BiotechnologiesPalo Alto$13.0M